Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Indira Varia, MD: Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
1
x
$
30.00
Treatment of Autism Spectrum Disorder in Children and Adolescents
1
x
$
30.00
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
1
x
$
30.00
Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder
1
x
$
30.00
Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
1
x
$
30.00
Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium
1
x
$
30.00
Clozapine Factors in Schizophrenia by Takefumi Suzuki
1
x
$
30.00
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
1
x
$
30.00
Theodore J. Anfinson, MD: Akathisia, Panic, Agoraphobia, and Major Depression Following Brief Exposure to Metoclopramide
1
x
$
30.00
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
1
x
$
30.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers
1
x
$
30.00
View Cart
Checkout
Home
DA Sychev
“Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers
$
30.00
Add to cart
Details
Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis
$
30.00
Add to cart
Details
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
$
30.00
Add to cart
Details
Association of CYP2D6*4 Polymorphism with the Steady- State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders
$
30.00
Add to cart
Details
Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses
$
30.00
Add to cart
Details
Influence of CYP2C19*17 Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive Disorder
$
30.00
Add to cart
Details
Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
